| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 621,000 | 491,000 | 441,000 | 573,000 | | Cost of Revenue | 157,000 | 193,000 | 142,000 | 164,000 | | | Gross Profit | 464,000 | 298,000 | 299,000 | 409,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 65,000 | 25,000 | 83,000 | 59,000 | | Non Recurring | 22,000 |
-
| 437,000 | 289,000 | | Others | 205,000 | 196,000 | 200,000 | 198,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 172,000 | 77,000 | (421,000) | (137,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (35,000) | (143,000) | 65,000 | 642,000 | | Earnings Before Interest And Taxes | 137,000 | (66,000) | (356,000) | 505,000 | | Interest Expense | 23,000 | 23,000 | 18,000 | 17,000 | | Income Before Tax | 114,000 | (89,000) | (374,000) | 488,000 | | Income Tax Expense | 8,000 | (32,000) | (186,000) | 183,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 106,000 | (57,000) | (188,000) | 305,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 106,000 | (57,000) | (188,000) | 305,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $106,000 | ($57,000) | ($188,000) | $305,000 |
|
0.44% Nasdaq 
Income Statement
